JEFFREY TUAZON: Open Payments
NPI 1518674621 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,199 in 174 payments from 17 companies in 2025. Trend: 2023 $317 · 2024 $833 · 2025 $3,199
Food & beverage: $2,762Consulting: $250Education: $187
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 24 | $544 |
| Organon LLC | 16 | $315 |
| Galderma Laboratories, L.P. | 13 | $305 |
| PFIZER INC. | 25 | $283 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| LEO Pharma Inc. | 18 | $246 |
| ABBVIE INC. | 16 | $212 |
| Regeneron Healthcare Solutions, Inc. | 9 | $176 |
| GENZYME CORPORATION | 12 | $149 |
| Arcutis Biotherapeutics, Inc. | 11 | $138 |
Products named: OPZELURA, DUPIXENT, VTAMA, NEMLUVIO, CIBINQO, Neo-Synalar, ADBRY, Zoryve.
Industry payments across NJ — which companies pay providers there.
